Entries of van Griensven, Martijn on the publication server
![]() | Up a level |
Number of items: 3.
2021
Madry, Henning, Grässel, Susanne, Nöth, Ulrich, Relja, Borna
, Bernstein, Anke, Docheva, Denitsa
, Kauther, Max Daniel, Katthagen, Jan Christoph, Bader, Rainer, van Griensven, Martijn
, Wirtz, Dieter C., Raschke, Michael J. and Huber-Lang, Markus
(2021)
The future of basic science in orthopaedics and traumatology: Cassandra or Prometheus?
European Journal of Medical Research 26 (1).
Fulltext not available.
, Bernstein, Anke, Docheva, Denitsa
, Kauther, Max Daniel, Katthagen, Jan Christoph, Bader, Rainer, van Griensven, Martijn
, Wirtz, Dieter C., Raschke, Michael J. and Huber-Lang, Markus
(2021)
The future of basic science in orthopaedics and traumatology: Cassandra or Prometheus?
European Journal of Medical Research 26 (1).
Fulltext not available.
2019
Wolff, Paul, Heimann, Laura, Liebsch, Gregor, Meier, Robert J., Gutbrod, Martin, van Griensven, Martijn and Balmayor, Elizabeth R.
(2019)
Oxygen-distribution within 3-D collagen I hydrogels for bone tissue engineering.
Materials Science and Engineering: C 95, pp. 422-427.
Fulltext not available.
2004
Seekamp, Andreas, van Griensven, Martijn
, Dhondt, Erwin, Diefenbeck, Michael, Demeyer, Ignace, Vundelinckx, Guy, Haas, Norbert, Schaechinger, Ulrich, Wolowicka, Laura, Rammelt, Stefan, Stroobants, Jan, Marzi, Ingo, Brambrink, Ansgar M., Dziurdzik, Piotr, Gasiorowski, Jacek, Redl, Heinz, Beckert, Michael and Khan-Boluki, Jasmin
(2004)
The effect of anti-L-selectin (aselizumab) in multiple traumatized patients—Results of a phase II clinical trial*.
Critical Care Medicine 32 (10), pp. 2021-2028.
Fulltext not available.
, Dhondt, Erwin, Diefenbeck, Michael, Demeyer, Ignace, Vundelinckx, Guy, Haas, Norbert, Schaechinger, Ulrich, Wolowicka, Laura, Rammelt, Stefan, Stroobants, Jan, Marzi, Ingo, Brambrink, Ansgar M., Dziurdzik, Piotr, Gasiorowski, Jacek, Redl, Heinz, Beckert, Michael and Khan-Boluki, Jasmin
(2004)
The effect of anti-L-selectin (aselizumab) in multiple traumatized patients—Results of a phase II clinical trial*.
Critical Care Medicine 32 (10), pp. 2021-2028.
Fulltext not available.
